Technology Transfer is an intensely dynamic field, and the process of moving federal scientific and technological research from the lab to the marketplace teems with original and innovative approaches.
FedTech, a venture firm that was formed in 2015 as a catalyst for deep-tech innovation, has pioneered one of these innovative approaches, the Startup Studio.
The Startup Studio is a highly creative approach bringing together research scientists from federal agencies, universities, and Federally Funded Research and Development Centers with diverse entrepreneurs, such as investors, venture capitalists, subject matter experts, and potential “angels” to bring the benefits of federal research to society through the commercial world.
The FedTech Startup Studio consists of three components, and a NIST team is participating in all three phases of this year’s program.
Phase One began in the summer of 2022 when federal and university researchers were matched with entrepreneurs whose interests aligned with the research topics. A team was formed for each technology, and the participants discussed specifics of the science and explored aspects of commercialization and business organization. The teams practiced how to pitch the project to garner investment and promote commercial development.
Phase One culminated in Pitch Day on February 1. Each team presented its technology to a panel of scientists and entrepreneurs, and the panel critiqued the presentations and suggested refinements and additional avenues of approach. The federally-funded research discussed in the meeting spanned a wide range. Technologies included a new approach to prevent blood clotting in the lungs, a precision tool for dealing with sepsis, and using Artificial Intelligence to capture data missing from patient records and assess the missing data’s importance to a patient’s treatment.
The team from NIST presented the ongoing research of three NIST scientists to develop an Optoflui ..
Support the originator by clicking the read the rest link below.
